What is Revivogen and how does it help in treating hair loss?

Revivogen is a line of products manufactured by Los Angeles-based company Advanced Skin & Hair Inc. The company’s founder and CEO is Dr. Alex Khadavi, a board-certified dermatologist with a private practice in Los Angeles who is also an instructor in dermatology at the University of Southern California. Originally inspired by his own experience with the onset of hair loss as a young man, Dr. Khadavi developed Revivogen as a natural alternative to pharmaceutical DHT inhibitors after years of research on the causes of hair loss and the treatments available.

Revivogen has been on the market since 1999 and is not approved by the FDA. However it should be remembered that it does not require FDA approval as all its active ingredients are natural.

For many consumers, the company’s branding of Revivogen as a treatment that only contains naturally occurring DHT inhibitors is one of the most attractive things about it. Furthermore, it is a topical solution that is applied directly to the scalp, so unlike the drugs finasteride and dutasteride, its inhibition of DHT is specific to scalp tissue and does not result in systemic side effects. Like dutasteride, Revivogen antagonizes types I and II of the 5-alpha-reductase enzyme responsible for metabolizing testosterone to DHT, a process that ultimately contributes to hair loss in those who are genetically predisposed.

By inhibiting both types 5-alpha-reductase with naturally available ingredients and localizing the effects of treatment to the scalp, its proponents believe that Revivogen is more effective than finasteride (which only targets type I 5-alpha-reductase) and safer than both finasteride and dutasteride. Because it is not a systemic treatment acting against DHT throughout the body, it is safe for use by men and women alike and the only side effect reported is occasional burning of the scalp.

  Avoid eating mango and watermelon in the rain, these fruits and vegetables do harm

In addition to its properties as a blend of natural DHT inhibitors, Revivogen has another advantage compared to pharmaceutical treatments. It doesn’t stop at inhibiting the conversion of testosterone to DHT, it also works to block the process by which DHT binds to androgen receptors within hair follicles. In other words, like other treatments, it first reduces the amount of DHT produced, but protects the follicles from damage from exposure to any DHT still present in the scalp.

The natural ingredients present in Revivogen are Gamma Linolenic Acid (GLA), Alpha Linolenic Acid (ALA), Linoleic Acid, Oleic Acid, Azelaic Acid, Vitamin B6, Zinc, Saw Palmetto Extract, Beta-Sitosterol and Procyanidin Oligomers. Many users apply it once daily, often at bedtime. The product range also includes a shampoo and a conditioner that can be used to help hair appear thicker and fuller.

A 3-month supply of the topical solution (known as Revivogen Scalp Therapy) currently costs $89, but if you want the shampoo and conditioner with it, your 3-month supply will cost $119. Although shampoo and conditioner can help your hair look thicker and healthier, Revivogen’s DHT blocking effects come exclusively from the topical solution, so you can probably skip everything else if you want to cut costs and focus on action at the level of your follicles. You may need to use Revivogen for up to 6 months before you see any benefits.

Revivogen may be used in conjunction with pharmaceutical DHT inhibitors or regrowth agents such as finasteride (Propecia) and minoxidil (Rogaine), and some people prefer to use all 3 treatments as part of a hair growth maintenance regime. If you use both Revivogen and Minoxidil it is important to use them at different times of the day so that each can work its magic without the other interfering.

  Men Over 40 Can Build Healthy Shoulders and Strong Abs With 1 Move

The problem with Revivogen is that since it is not approved or regulated by the FDA, there is currently no clinical data available regarding its efficacy as a hair loss treatment.



Source by Mac Morris

Leave a Comment